Joe Papa, new Emergent BioSolutions CEO (Ryan Remiorz/The Canadian Press via AP Images, File)
February 21, 2024 11:53 AM EST
People
Pharma

Emer­gent calls on new CEO Joe Pa­pa to lead turn­around fol­low­ing pan­dem­ic stum­bles

Nicole DeFeudis

Editor

Joe Pa­pa is known for putting him­self in a pick­le. He’s made a ca­reer out of turn­around at­tempts, most re­cent­ly at em­bat­tled Valeant Phar­ma­ceu­ti­cals. Next …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times